Here's the live share price of GKB Ophthalmics along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of GKB Ophthalmics has declined 0.76% CAGR. Over the past year, the corresponding return has been -26.73%.
GKB Ophthalmics’s current P/E of -12.31x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| GKB Ophthalmics | 12.15 | 15.28 | 1.84 | -20.06 | -26.73 | -27.96 | -0.76 |
| Lenskart Solutions | 9.46 | 9.30 | 22.22 | 23.98 | 23.98 | 7.43 | 4.39 |
| Kretto Syscon | 48.94 | -2.78 | -36.94 | -54.46 | -50.91 | 16.96 | 13.95 |
| Boston Bio Systems | -5.40 | -32.35 | -22.90 | -24.56 | -71.48 | -34.18 | -22.19 |
Over the last one year, GKB Ophthalmics has declined 26.73% compared to peers like Lenskart Solutions (23.98%), Kretto Syscon (-50.91%), Boston Bio Systems (-71.48%). From a 5 year perspective, GKB Ophthalmics has outperformed peers relative to Lenskart Solutions (4.39%) and Kretto Syscon (13.95%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 55.73 | 57.05 |
| 10 | 56.21 | 56.2 |
| 20 | 55.24 | 55.32 |
| 50 | 52.84 | 55.39 |
| 100 | 58.69 | 58.89 |
| 200 | 66.81 | 65.94 |
In the latest quarter, GKB Ophthalmics saw a rise in promoter holding to 51.12%, while DII stake unchanged at 0.00%, FII holding unchanged at 1.79%, and public shareholding moved down to 47.09% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Feb 13, 2026, 2:59 AM IST | GKB Ophthalmic - December 31, 2025 _Unaudited Standalone And Consolidated Financial Results |
| Feb 13, 2026, 2:36 AM IST | GKB Ophthalmic - Board Meeting Outcome for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarte |
| Jan 30, 2026, 10:40 PM IST | GKB Ophthalmic - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended D |
| Jan 20, 2026, 10:49 PM IST | GKB Ophthalmic - Intimation On Conversion Of Statutory Auditor''s Firm Into LLP- " MSKA & Associates" To MSKA & Associates LL |
| Jan 08, 2026, 9:41 PM IST | GKB Ophthalmic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
GKB Ophthalmics Ltd. is a Public Limited Listed company incorporated on 10/12/1981 and has its registered office in the State of Goa, India. Company's Corporate Identification Number(CIN) is L26109GA1981PLC000469 and registration number is 000469. Currently Company is involved in the business activities of Manufacture of ophthalmic goods, eyeglasses, sunglasses, lenses ground to prescription, contact lenses, safety goggles etc.. Company's Total Operating Revenue is Rs. 32.75 Cr. and Equity Capital is Rs. 5.04 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for GKB Ophthalmics is ₹61.55 as on Feb 16, 2026.
The GKB Ophthalmics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of GKB Ophthalmics is ₹31.02 Cr as on Feb 16, 2026.
Today’s highest and lowest price of GKB Ophthalmics are ₹63.30 and ₹58.80.
The 52-week high/low is the highest and lowest price at which GKB Ophthalmics stock has traded in the past 52-week or nearly a year. The 52-week high of GKB Ophthalmics is ₹91.70 and 52-week low of GKB Ophthalmics is ₹45.25 as on Feb 16, 2026.
The GKB Ophthalmics has shown returns of 0.62% over the past day, 15.28% for the past month, 1.84% over 3 months, -26.73% over 1 year, -27.96% across 3 years, and -0.76% over 5 years.
P/E ratio of and PB ratio of GKB Ophthalmics are -12.31 and 0.59 on Feb 16, 2026. While the company gives a dividend yield of 0.00 per annum.